According to previous findings, Corilagin can inhibit NLRP3 inflammasome activation and pyroptosis in ischemia-reperfusion induced intestinal and lung injury (38), and ameliorate atherosclerosis by restraining the TLR4 signaling pathway (17, 40). This evidence concerns the gene TLR4 and atherosclerosis.